NYSE:GSK | Market Exclusive

Home Tags NYSE:GSK

NICE Approves GlaxoSmithKline plc (ADR)(NYSE:GSK) Gene Therapy Strimvelis

Andy Parker - October 23, 2017 0

Positive Results Observed In Novartis AG (ADR)(NYSE:NVS) Immune Thrombocytopenia Therapy

- October 20, 2017 0

Novartis AG (ADR)(NYSE:NVS) To Shut Down Sandoz Generic Drugs Facility

- October 17, 2017 0

GlaxoSmithKline plc (ADR) (NYSE:GSK)’s Shingles Vaccine Likely To Get FDA Approval...

Andy Parker - September 14, 2017 0

Asthma Drug By AstraZeneca plc (ADR) (NYSE:AZN), Amgen, Inc. (NASDAQ:AMGN) Aimed...

- September 7, 2017 0

GlaxoSmithKline plc. (ADR)(NYSE:GSK) Restructuring Takes A Toll on Ionis Pharmaceuticals Inc....

Andy Parker - August 15, 2017 0

Ionis Pharmaceuticals Inc. (NASDAQ:IONS) Rallies On Improved Guidance

Andy Parker - August 14, 2017 0

GlaxoSmithKline plc (ADR) (NYSE:GSK) And Rolls Royce To Expect UK Fraud...

- August 11, 2017 0

How Novartis AG (ADR) (NYSE:NVS) Uses Proceeds From Asset Sales Would...

Andy Parker - August 3, 2017 0

GlaxoSmithKline plc (ADR)(NYSE:GSK) Axes More Than 30 Drug-Research Projects

Andy Parker - July 28, 2017 0

123...9 Page 2 of 9

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024

November 10, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024

October 27, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-14-24

October 13, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: NYSE:GSK